Advertisement
Advertisement
NBTX
Nanobiotix S.A. - ADR
35.26
USDSponsored
-0.47
-1.32%
Sep 15, 16:00 UTC -4
Closed
Pre-Market
34.68
-0.58
-1.66%
NBTX Earnings Reports
Positive Surprise Ratio
NBTX beat 4 of 16 last estimates.
25%
Next Report
Date of Next Report
Sep 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$30.50M
/-$0.11
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
+14.49%
/--
Nanobiotix S.A. - ADR earnings per share and revenue
On May 19, 2026, NBTX reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 30.50 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Attovia Therapeutics, Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$2.78
Actual
-$4.88
Surprise
-75.25%
Scribe Therapeutics Inc. Common Stock
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.03
Actual
-$2.62
Surprise
+13.59%
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Nanobiotix S.A. - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Nanobiotix S.A. - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nanobiotix S.A. - ADR's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Nanobiotix S.A. - ADR expected to report next?
The next earning report is scheduled for Sep 28, 2026.
What are the forecasts for Nanobiotix S.A. - ADR's next earnings report?
Based on 3
analysts, Nanobiotix S.A. - ADR is expected to report EPS of -$0.11 and revenue of $30.50M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.